Surgical Science Sweden Ab (publ)
(OTC) SUSRF
Surgical Science Sweden Ab (publ) Financials at a Glance
Market Cap
$144.91M
Revenue (TTM)
$991.67M
Net Income (TTM)
$66.73M
EPS (TTM)
$0.13
P/E Ratio
21.58
Dividend
$0.00
Beta (Volatility)
-0.07 (Low)
Dividend
$0.00
Beta (Volatility)
-0.07 (Low)
Price
$2.84
Volume
1,200
Open
$2.86
Price
$2.84
Volume
1,200
Open
$2.86
Previous Close
$2.84
Daily Range
$2.84 - $2.86
52-Week Range
$2.84 - $16.33
Dividend
$0.00
Beta (Volatility)
-0.07 (Low)
Price
$2.84
Volume
1,200
Open
$2.86
Previous Close
$2.84
Daily Range
$2.84 - $2.86
52-Week Range
$2.84 - $16.33
SUSRF News
SUSRF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Surgical Science Sweden Ab (publ)
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
313
CEO
Tom Englund
Website
www.surgical-science.comHeadquarters
Gothenburg, 412 50, SE
SUSRF Financials
Key Financial Metrics (TTM)
Gross Margin
64%
Operating Margin
8%
Net Income Margin
7%
Return on Equity
1%
Return on Capital
2%
Return on Assets
1%
Earnings Yield
4.63%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$144.91M
Shares Outstanding
51.03M
Volume
1.20K
Short Interest
0.00%
Avg. Volume
37.3
Financials (TTM)
Gross Profit
$575.46M
Operating Income
$108.70M
EBITDA
$191.86M
Operating Cash Flow
$79.59M
Capital Expenditure
$11.65M
Free Cash Flow
$67.95M
Cash & ST Invst.
$614.88M
Total Debt
$1.62M
Surgical Science Sweden Ab (publ) Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$268.18M
+6.6%
Gross Profit
$154.62M
-9.1%
Gross Margin
57.65%
N/A
Market Cap
$144.91M
N/A
Market Cap/Employee
$528.88K
N/A
Employees
274
N/A
Net Income
$33.17M
-8.5%
EBITDA
$70.77M
+80.9%
Quarterly Fundamentals
Net Cash
$613.26M
-16.3%
Accounts Receivable
$207.72M
-25.4%
Inventory
$205.46M
+14.4%
Long Term Debt
$1.62M
-99.4%
Short Term Debt
$0.00
N/A
Return on Assets
1.42%
N/A
Return on Invested Capital
1.72%
N/A
Free Cash Flow
$66.48M
+49.3%
Operating Cash Flow
$72.70M
+28.3%